Lavipharm S.A (LAVI) — Financial Flexibility Index
Lavipharm S.A (LAVI) has a Financial Flexibility Index of 0.24x as of December 2022. Free cash flow of €18.09 Million (operating CF €527.00K minus capex €17.56 Million) represents 0% of total liabilities (€73.89 Million). Check Lavipharm S.A PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lavipharm S.A Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Lavipharm S.A across 11 annual periods. See LAVI working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Lavipharm S.A (2014–2024)
Year-by-year free cash flow to debt coverage for Lavipharm S.A. For the full company profile including market capitalisation, see LAVI market cap.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.20x | €14.28 Million | €4.64 Million | €72.52 Million | ▲ +227.4% |
| 2023 | 0.06x | €4.33 Million | €284.00K | €72.02 Million | ▼ -88.6% |
| 2022 | 0.53x | €38.96 Million | €3.35 Million | €73.89 Million | ▲ +476.2% |
| 2021 | 0.09x | €5.74 Million | €3.82 Million | €62.68 Million | ▲ +33.1% |
| 2020 | 0.07x | €4.33 Million | €2.85 Million | €62.94 Million | ▼ -17.4% |
| 2019 | 0.08x | €5.31 Million | €2.89 Million | €63.82 Million | ▲ +108.6% |
| 2018 | 0.04x | €2.45 Million | €1.42 Million | €61.43 Million | ▲ +38.4% |
| 2017 | 0.03x | €1.86 Million | €1.51 Million | €64.73 Million | ▲ +227.7% |
| 2016 | 0.01x | €703.00K | €606.00K | €80.00 Million | ▲ +115.4% |
| 2015 | 0.00x | €599.00K | €576.00K | €146.80 Million | ▼ -84.9% |
| 2014 | 0.03x | €3.58 Million | €2.38 Million | €132.79 Million | — |